Abivax S.A.(ABVX)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Pending next ranking run
This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
ABVX Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Abivax S.A. (ABVX), a Healthcare sector company. ABVX is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of ABVX by reported 13-F value include TCG Crossover Management,, UBS Group AG, Darwin Global Management, Ltd., based on the most recent SEC filings. ABVX trades on the Nasdaq exchange and files with the SEC under CIK 1956827. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ABVX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Abivax S.A. directly from SEC EDGAR.
Get alerted when ABVX's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Abivax S.A. including:
Top Institutional Holders of ABVX
TCG Crossover Management, LLC
$721.7M6,481,085 shUBS Group AG
$506.4M4,547,406 shDarwin Global Management, Ltd.
$352.1M3,468,657 shMORGAN STANLEY
$189.8M1,704,958 shVestal Point Capital, LP
$167.0M1,500,000 shCaligan Partners LP
$162.8M1,461,924 shADAR1 Capital Management, LLC
$155.2M1,394,019 shWESTFIELD CAPITAL MANAGEMENT CO LP
$147.3M1,322,938 shFMR LLC
$143.2M1,286,373 shHelikon Investments Ltd
$112.8M1,013,324 sh
| Fund | Value | Shares |
|---|---|---|
| TCG Crossover Management, LLC | $721.7M | 6,481,085 |
| UBS Group AG | $506.4M | 4,547,406 |
| Darwin Global Management, Ltd. | $352.1M | 3,468,657 |
| MORGAN STANLEY | $189.8M | 1,704,958 |
| Vestal Point Capital, LP | $167.0M | 1,500,000 |
| Caligan Partners LP | $162.8M | 1,461,924 |
| ADAR1 Capital Management, LLC | $155.2M | 1,394,019 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $147.3M | 1,322,938 |
| FMR LLC | $143.2M | 1,286,373 |
| Helikon Investments Ltd | $112.8M | 1,013,324 |
More Healthcare Companies
View all Healthcare →Put ABVX on your watchlist
Track score changes the day Abivax S.A. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ABVX a good stock to buy?
13F Pro's AI-powered analysis of Abivax S.A. (ABVX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ABVX are available on the ABVX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own ABVX?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ABVX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Abivax S.A.'s investment landscape.